24 completed, 3 active not recruiting, 2 terminated. 11 Phase 3, 11 Phase 4, 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 10, Active not recruiting 1 |
| Phase 4 | 11 | Completed 7, Active not recruiting 2, Terminated 2 |
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow Cervarix: new trials by email Literature Review of Cervarix trials Research Report on Cervarix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Questionnaire Administration, Recombinant Human Papillomavirus Bivalent Vaccine - Human Papillomavirus-Related Cervical Carcinoma | Phase 4 | Active not recruiting | National Cancer Institute (NCI) | 5000 | 2022-03-01 | 2026-10-22 |
| Safety and Effects of Using Prime-boost HIVIS DNA and MVA-CMDR Vaccine Regimens With or Without Toll-like Receptor 4 Agonist on HIV Reservoirs in Perinatally HIV Infected Children and Youth HIVIS DNA/MVA-CMDR, HIVIS DNA + Cervarix and MVA-CMDR, Cervarix - HIV Infections | Phase 1 | Completed | Henry M. Jackson Foundation for the Advancement of Military Medicine | 25 | 2022-02-18 | 2025-08-11 |
| Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine, Recombinant Human Papillomavirus Bivalent Vaccine - Human Papillomavirus-Related Cervical Carcinoma | Phase 3 | Completed | National Cancer Institute (NCI) | 1240 | 2019-04-01 | 2025-08-03 |
| Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Questionnaire Administration, Recombinant Human Papillomavirus Bivalent Vaccine - Human Papillomavirus Infection, Human Papillomavirus-Related Cervical Carcinoma | Phase 4 | Active not recruiting | National Cancer Institute (NCI) | 27945 | 2017-11-29 | 2025-09-04 |
| A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls bivalent HPV vaccine, nonavalent HPV vaccine - Human Papilloma Virus | Phase 3 | Active not recruiting | London School of Hygiene and Tropical Medicine | 930 | 2017-02-23 | 2026-09-08 |
| FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program CERVARIX, GARDASIL - Cervical Intraepithelial Neoplasia, HPV-Related Cervical Carcinoma | Phase 4 | Completed | Instituto Nacional de Salud Publica, Mexico | 3000 | 2017-01-03 | 2020-08-10 |
| Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®) cervarix, Gardasil - Infection With Human Papillomavirus | Phase 4 | Completed | University Hospital, Ghent | 12 | 2013-06-25 | 2022-12-09 |
| Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK Data Collection, Cervarix - Infections, Papillomavirus | Completed | GlaxoSmithKline | 1046 | 2012-11-01 | 2013-09-30 | |
| Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old Cervarix, Priorix, Infanrix - Infections, Papillomavirus | Phase 3 | Completed | GlaxoSmithKline | 148 | 2012-10-15 | 2020-04-10 |
| Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females Cervarix, Gardasil, Placebo - Infections, Papillomavirus | Phase 3 | Completed | GlaxoSmithKline | 1079 | 2011-11-21 | 2019-11-15 |
| Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects Gynaecological follow-up, Cervarix, Placebo control - Infections, Papillomavirus | Phase 3 | Completed | GlaxoSmithKline | 34 | 2011-09-12 | 2019-10-30 |
| Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults Gardasil, Cervarix - HIV, Human Papillomavirus | Phase 4 | Completed | University of Aarhus | 92 | 2011-08-01 | 2013-08-16 |
| Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls GSK Biologicals' HPV vaccine 580299 - Infections, Papillomavirus | Phase 3 | Completed | GlaxoSmithKline | 1447 | 2011-06-29 | 2020-06-09 |
| Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females GSK Biologicals' HPV vaccine 580299, Merck's Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine (Gardasil) - Infections, Papillomavirus, Papillomavirus Vaccines | Phase 4 | Completed | GlaxoSmithKline | 873 | 2010-10-26 | 2020-07-21 |
| Efficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) Vaccination Cervarix, Engerix-B - Human Papillomavirus Infection | Phase 4 | Terminated | National Institute for Public Health and the Environment (RIVM) | 2010-09-01 | 2010-03-19 | |
| Evaluation of Immunogenicity Levels in Women With HPV Vaccine in Mexico Bivalent Vaccines, Tetravalent Vaccine - Healthy | Phase 4 | Completed | Instituto Nacional de Salud Publica, Mexico | 2000 | 2009-11-01 | 2018-08-27 |
| Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls Cervarix, Gardasil - HPV Infections | Phase 4 | Completed | Public Health England | 400 | 2009-09-01 | 2020-10-01 |
| Safety Study of GSK Biologicals' HPV Vaccine (GSK-580299) in Healthy Female Subjects. Cervarix - Infections, Papillomavirus | Phase 3 | Completed | GlaxoSmithKline | 92 | 2009-05-01 | 2016-10-20 |
| A Study to Assess the Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix) in Healthy Female Filipino Subjects Vaccinated According to the Prescribing Information From the Age of 10 Years Onwards. Cervarix - Human Papillomavirus Infection Leading to Cervical Cancer | Phase 4 | Terminated | GlaxoSmithKline | 743 | 2008-09-17 | 2019-11-05 |
| Cervarix Long-term Safety Surveillance Cervarix, Data collection - Infections, Papillomavirus | Completed | GlaxoSmithKline | 2945 | 2008-08-01 | 2015-04-06 |
Showing 20 of 29. Sign in to see all of them.
Papillomavirus Infections (20) · Uterine Cervical Neoplasms (9) · Virus Diseases (2) · Abortion, Spontaneous (1) · Acquired Immunodeficiency Syndrome (1) · Autoimmune Diseases (1) · HIV Infections (1) · Infections (1) · Uterine Cervical Dysplasia (1)
GlaxoSmithKline (18) · National Cancer Institute (NCI) (3) · Instituto Nacional de Salud Publica, Mexico (2) · Henry M. Jackson Foundation for the Advancement of Military Medicine (1) · London School of Hygiene and Tropical Medicine (1) · National Institute for Public Health and the Environment (RIVM) (1) · Public Health England (1) · University Hospital, Ghent (1) · University of Aarhus (1)
Canada (4) · Mexico (4) · United Kingdom (4) · Costa Rica (3) · Germany (3) · Singapore (3) · Thailand (3) · United States (3) · Brazil (2) · Hong Kong (2) · Netherlands (2) · Philippines (2) · Portugal (2) · Russia (2) · South Africa (2)
Aimee R Kreimer (3) · Aurelio Cruz, Valdez (1) · Deborah Watson-Jones, Dr (1) · Eduardo C Lazcano, Phd, MD (1) · Geert Leroux-Roels, MD, PhD (1) · Janet L. Pacheco (1) · Lars Toft, MD (1) · Merlin Robb, MD (1)
PMID 41276263, PMID 24731816, PMID 25424918, PMID 22327492, PMID 23063422, PMID 23650505, PMID 24138429, PMID 24273179, PMID 24355090, PMID 24553190, PMID 24576907, PMID 25208608, PMID 25593103, PMID 26176261, PMID 26685704, PMID 27566633, PMID 28319456, PMID 29055031, PMID 29845626, PMID 30085139, PMID 30715452, PMID 30926298, PMID 31273942, PMID 31464859, PMID 31736068, PMID 31824976, PMID 31829767, PMID 32078808, PMID 32161969, PMID 32574384, PMID 33421649, PMID 33639181, PMID 33857679, PMID 34097688, PMID 34857420, PMID 35649600, PMID 36113531, PMID 36113532, PMID 36460537, PMID 38365419, PMID 39890232, PMID 41337735, PMID 41419735, PMID 42378813
2017 (2), 2004 (1), 2005 (1), 2009 (1)